Company · CIK 1671818
Oncorus, Inc.
| CIK | 1671818 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-11-12 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-260718 | 2021-11-03 | 2023-07-19 | 4 | |
| 333-252896 | 2021-02-09 | 2021-02-12 | 3 | |
| 333-248757 | 2020-09-11 | 2020-10-02 | 4 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-07-19 | RWWithdrawn | 333-260718 | 0001193125-23-189620 |
| 2021-11-19 | 424B5Shelf takedown | 333-260718 | 0001193125-21-335256 |
| 2021-11-12 | EFFECTDeclared effective | 333-260718 | 9999999995-21-004329 |
| 2021-11-03 | S-3Shelf registered | 333-260718 | 0001193125-21-318564 |
| 2021-02-12 | 424B4Final prospectus | 333-252896 | 0001193125-21-041610 |
| 2021-02-11 | EFFECTDeclared effective | 333-252896 | 9999999995-21-000624 |
| 2021-02-09 | S-1Registration filed | 333-252896 | 0001193125-21-034477 |
| 2021-01-28 | DRSDraft made public | 377-04112 | 0000950123-21-000665 |
| 2020-10-02 | 424B4Final prospectus | 333-248757 | 0001193125-20-262475 |
| 2020-10-01 | EFFECTDeclared effective | 333-248757 | 9999999995-20-002654 |
| 2020-09-28 | S-1/AAmendment | 333-248757 | 0001193125-20-255117 |
| 2020-09-11 | S-1Registration filed | 333-248757 | 0001193125-20-244199 |
| 2019-10-31 | DRSDraft made public | 377-02886 | 0000950123-19-009877 |